+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Pharmaceuticals Global Industry Almanac 2015-2024

  • ID: 5131032
  • Report
  • June 2020
  • Region: Global
  • 552 pages
  • MarketLine

FEATURED COMPANIES

  • Almirall S.A.
  • AstraZeneca AB
  • Boehringer Ingelheim GmbH
  • EMS Sigma Pharma
  • Johnson & Johnson
  • Merck & Co., Inc.
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Pharmaceuticals Global Industry Almanac 2015-2024

Summary

Global Pharmaceuticals industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2015-19, and forecast to 2024). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Essential resource for top-line data and analysis covering the global pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends and leading companies.

Key Highlights
  • The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
  • Market values have been calculated at ex-factory prices (the value at which manufacturers sell the drugs to distributors).
  • Any currency conversions used in the production of this report have been calculated at constant 2019 annual average exchange rates.
  • Figures presented in this report are calculated applying the "middle path" scenario - this is based on the current situation in countries where the epidemic burst first, like China as a model countries and the announcements made by governments, stating that the abnormal situation may last up to six months.
  • The assumption has been made that after this time the economy will gradually go back to the levels recorded before the pandemics by the end of the year. It is also assumed that there is no widespread economic crisis as seen back in 2008 due to announced pay-outs across countries.
  • At the moment of preparation of this report in April 2020 the economic implications of the lock downs of many economics are still very difficult to predict as there is no indication how long the pandemics could last, the number of sectors forced to stay closed and the scale of the governmental' aid involved. At the same time the weight of the pandemic seriousness is applied to the individual countries in this report based on death to population ratio recorded in countries.
  • The majority of the industries will see the decline in the volume of the goods and services offered by companies. Usually the lower demand would cause a decrease in the prices level. However, amid many governments’ ordered for many industries to lock down and so the supply chain is distorted that in great pictures mitigate the results of lower demand.
  • Applied scenarios differ depending on the individual sector, however generally sectors which involve intensive manual labor and face to face interaction seem to be hit the most by the present situation. On the other hand the internet based businesses as well as the producers of the vital, subsisted products and services seem to take advantage of the current events.
  • The global pharmaceuticals market had total revenues of $1,057,513.1m in 2019, representing a compound annual growth rate (CAGR) of 3.6% between 2015 and 2019.
  • The United States, China, and Japan are some of the largest pharmaceutical markets globally, alongside large European markets such as Germany, France, Spain, and Italy.
  • Historically, China is producing some of the strongest growth every year, whilst the European markets have been stifled due to current healthcare spending cultures in the region.
Scope
  • Save time carrying out entry-level research by identifying the size, growth, and leading players in the global pharmaceuticals market
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the global pharmaceuticals market
  • Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the global pharmaceuticals market with five year forecasts
Reasons to Buy
  • What was the size of the global pharmaceuticals market by value in 2019?
  • What will be the size of the global pharmaceuticals market in 2024?
  • What factors are affecting the strength of competition in the global pharmaceuticals market?
  • How has the market performed over the last five years?
  • Who are the top competitors in the global pharmaceuticals market?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Almirall S.A.
  • AstraZeneca AB
  • Boehringer Ingelheim GmbH
  • EMS Sigma Pharma
  • Johnson & Johnson
  • Merck & Co., Inc.
1. Executive Summary

2. Introduction

3. Global Pharmaceuticals

4. Pharmaceuticals in Asia-Pacific

5. Pharmaceuticals in Europe

6. Pharmaceuticals in France

7. Pharmaceuticals in Germany

8. Pharmaceuticals in Australia

9. Pharmaceuticals in Brazil

10. Pharmaceuticals in Canada

11. Pharmaceuticals in China

12. Pharmaceuticals in India

13. Pharmaceuticals in Indonesia

14. Pharmaceuticals in Italy

15. Pharmaceuticals in Japan

16. Pharmaceuticals in Mexico

17. Pharmaceuticals in The Netherlands

18. Pharmaceuticals in North America

19. Pharmaceuticals in Russia

20. Pharmaceuticals in Scandinavia

21. Pharmaceuticals in Singapore

22. Pharmaceuticals in South Africa

23. Pharmaceuticals in South Korea

24. Pharmaceuticals in Spain

25. Pharmaceuticals in Turkey

26. Pharmaceuticals in The United Kingdom

27. Pharmaceuticals in The United States

28. Company Profiles

29. Appendix

List of Tables
Table 1: Global pharmaceuticals market value: $ billion, 2015-19
Table 2: Global pharmaceuticals market geography segmentation: $ billion, 2019
Table 3: Global pharmaceuticals market share: % share, by value, 2019
Table 4: Global pharmaceuticals market value forecast: $ billion, 2019-24
Table 5: Global size of population (million), 2015-19
Table 6: Global GDP (constant 2005 prices, $ billion), 2015-19
Table 7: Global GDP (current prices, $ billion), 2015-19
Table 8: Global inflation, 2015-19
Table 9: Global consumer price index (absolute), 2015-19
Table 10: Global exchange rate, 2015-19
Table 11: Asia-Pacific pharmaceuticals market value: $ billion, 2015-19
Table 12: Asia-Pacific pharmaceuticals market geography segmentation: $ billion, 2019
Table 13: Asia-Pacific pharmaceuticals market share: % share, by value, 2019
Table 14: Asia-Pacific pharmaceuticals market value forecast: $ billion, 2019-24
Table 15: Europe pharmaceuticals market value: $ billion, 2015-19
Table 16: Europe pharmaceuticals market geography segmentation: $ billion, 2019
Table 17: Europe pharmaceuticals market share: % share, by value, 2019
Table 18: Europe pharmaceuticals market value forecast: $ billion, 2019-24
Table 19: Europe size of population (million), 2015-19
Table 20: Europe GDP (constant 2005 prices, $ billion), 2015-19
Table 21: Europe GDP (current prices, $ billion), 2015-19
Table 22: Europe inflation, 2015-19
Table 23: Europe consumer price index (absolute), 2015-19
Table 24: Europe exchange rate, 2015-19
Table 25: France pharmaceuticals market value: $ billion, 2015-19
Table 26: France pharmaceuticals market geography segmentation: $ billion, 2019
Table 27: France pharmaceuticals market share: % share, by value, 2019
Table 28: France pharmaceuticals market value forecast: $ billion, 2019-24
Table 29: France size of population (million), 2015-19
Table 30: France GDP (constant 2005 prices, $ billion), 2015-19
Table 31: France GDP (current prices, $ billion), 2015-19
Table 32: France inflation, 2015-19
Table 33: France consumer price index (absolute), 2015-19
Table 34: France exchange rate, 2015-19
Table 35: Germany pharmaceuticals market value: $ billion, 2015-19
Table 36: Germany pharmaceuticals market geography segmentation: $ billion, 2019
Table 37: Germany pharmaceuticals market share: % share, by value, 2019
Table 38: Germany pharmaceuticals market value forecast: $ billion, 2019-24
Table 39: Germany size of population (million), 2015-19
Table 40: Germany GDP (constant 2005 prices, $ billion), 2015-19
Table 41: Germany GDP (current prices, $ billion), 2015-19
Table 42: Germany inflation, 2015-19
Table 43: Germany consumer price index (absolute), 2015-19
Table 44: Germany exchange rate, 2015-19
Table 45: Australia pharmaceuticals market value: $ billion, 2015-19
Table 46: Australia pharmaceuticals market geography segmentation: $ billion, 2019
Table 47: Australia pharmaceuticals market share: % share, by value, 2019
Table 48: Australia pharmaceuticals market value forecast: $ billion, 2019-24
Table 49: Australia size of population (million), 2015-19
Table 50: Australia GDP (constant 2005 prices, $ billion), 2015-19
Table 51: Australia GDP (current prices, $ billion), 2015-19
Table 52: Australia inflation, 2015-19
Table 53: Australia consumer price index (absolute), 2015-19
Table 54: Australia exchange rate, 2015-19
Table 55: Brazil pharmaceuticals market value: $ billion, 2015-19
Table 56: Brazil pharmaceuticals market geography segmentation: $ billion, 2019
Table 57: Brazil pharmaceuticals market share: % share, by value, 2019
Table 58: Brazil pharmaceuticals market value forecast: $ billion, 2019-24
Table 59: Brazil size of population (million), 2015-19

List of Figures
Figure 1: Global pharmaceuticals market value: $ billion, 2015-19
Figure 2: Global pharmaceuticals market geography segmentation: % share, by value, 2019
Figure 3: Global pharmaceuticals market share: % share, by value, 2019
Figure 4: Global pharmaceuticals market value forecast: $ billion, 2019-24
Figure 5: Forces driving competition in the global pharmaceuticals market, 2019
Figure 6: Drivers of buyer power in the global pharmaceuticals market, 2019
Figure 7: Drivers of supplier power in the global pharmaceuticals market, 2019
Figure 8: Factors influencing the likelihood of new entrants in the global pharmaceuticals market, 2019
Figure 9: Factors influencing the threat of substitutes in the global pharmaceuticals market, 2019
Figure 10: Drivers of degree of rivalry in the global pharmaceuticals market, 2019
Figure 11: Asia-Pacific pharmaceuticals market value: $ billion, 2015-19
Figure 12: Asia-Pacific pharmaceuticals market geography segmentation: % share, by value, 2019
Figure 13: Asia-Pacific pharmaceuticals market share: % share, by value, 2019
Figure 14: Asia-Pacific pharmaceuticals market value forecast: $ billion, 2019-24
Figure 15: Forces driving competition in the pharmaceuticals market in Asia-Pacific, 2019
Figure 16: Drivers of buyer power in the pharmaceuticals market in Asia-Pacific, 2019
Figure 17: Drivers of supplier power in the pharmaceuticals market in Asia-Pacific, 2019
Figure 18: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Asia-Pacific, 2019
Figure 19: Factors influencing the threat of substitutes in the pharmaceuticals market in Asia-Pacific, 2019
Figure 20: Drivers of degree of rivalry in the pharmaceuticals market in Asia-Pacific, 2019
Figure 21: Europe pharmaceuticals market value: $ billion, 2015-19
Figure 22: Europe pharmaceuticals market geography segmentation: % share, by value, 2019
Figure 23: Europe pharmaceuticals market share: % share, by value, 2019
Figure 24: Europe pharmaceuticals market value forecast: $ billion, 2019-24
Figure 25: Forces driving competition in the pharmaceuticals market in Europe, 2019
Figure 26: Drivers of buyer power in the pharmaceuticals market in Europe, 2019
Figure 27: Drivers of supplier power in the pharmaceuticals market in Europe, 2019
Figure 28: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Europe, 2019
Figure 29: Factors influencing the threat of substitutes in the pharmaceuticals market in Europe, 2019
Figure 30: Drivers of degree of rivalry in the pharmaceuticals market in Europe, 2019
Figure 31: France pharmaceuticals market value: $ billion, 2015-19
Figure 32: France pharmaceuticals market geography segmentation: % share, by value, 2019
Figure 33: France pharmaceuticals market share: % share, by value, 2019
Figure 34: France pharmaceuticals market value forecast: $ billion, 2019-24
Figure 35: Forces driving competition in the pharmaceuticals market in France, 2019
Figure 36: Drivers of buyer power in the pharmaceuticals market in France, 2019
Figure 37: Drivers of supplier power in the pharmaceuticals market in France, 2019
Figure 38: Factors influencing the likelihood of new entrants in the pharmaceuticals market in France, 2019
Figure 39: Factors influencing the threat of substitutes in the pharmaceuticals market in France, 2019
Figure 40: Drivers of degree of rivalry in the pharmaceuticals market in France, 2019
Figure 41: Germany pharmaceuticals market value: $ billion, 2015-19
Figure 42: Germany pharmaceuticals market geography segmentation: % share, by value, 2019
Figure 43: Germany pharmaceuticals market share: % share, by value, 2019
Figure 44: Germany pharmaceuticals market value forecast: $ billion, 2019-24
Figure 45: Forces driving competition in the pharmaceuticals market in Germany, 2019
Figure 46: Drivers of buyer power in the pharmaceuticals market in Germany, 2019
Figure 47: Drivers of supplier power in the pharmaceuticals market in Germany, 2019
Figure 48: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Germany, 2019
Figure 49: Factors influencing the threat of substitutes in the pharmaceuticals market in Germany, 2019
Figure 50: Drivers of degree of rivalry in the pharmaceuticals market in Germany, 2019
Figure 51: Australia pharmaceuticals market value: $ billion, 2015-19
Figure 52: Australia pharmaceuticals market geography segmentation: % share, by value, 2019
Figure 53: Australia pharmaceuticals market share: % share, by value, 2019
Figure 54: Australia pharmaceuticals market value forecast: $ billion, 2019-24
Figure 55: Forces driving competition in the pharmaceuticals market in Australia, 2019
Figure 56: Drivers of buyer power in the pharmaceuticals market in Australia, 2019
Figure 57: Drivers of supplier power in the pharmaceuticals market in Australia, 2019
Figure 58: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Australia, 2019
Figure 59: Factors influencing the threat of substitutes in the pharmaceuticals market in Australia, 2019
Figure 60: Drivers of degree of rivalry in the pharmaceuticals market in Australia, 2019
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • A Menarini Industrie Farmaceutiche Riunite Srl
  • Abdi Ibrahim Ilac Sanayi ve Ticaret AS
  • Ache Laboratorios Farmaceuticos SA
  • Adcock Ingram Holdings Ltd
  • Almirall S.A.
  • Apotex Pharmachem Inc
  • Aspen Pharmacare Holdings Ltd
  • Astellas Pharma Inc.
  • AstraZeneca AB
  • Aurobindo Pharma Ltd
  • Bayer AG
  • Boehringer Ingelheim GmbH
  • Chiesi Farmaceutici SpA
  • Chong Kun Dang Pharmaceutical Corp
  • Daewoong Pharmaceutical Co Ltd
  • Daiichi Sankyo Co Ltd
  • Dr. Reddy's Laboratories Limited
  • EMS Sigma Pharma
  • F. Hoffmann-La Roche Ltd
  • GlaxoSmithKline Plc
  • Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
  • Guangzhou Pharmaceuticals Corp
  • Hanmi Pharmaceuticals Co Ltd
  • Johnson & Johnson
  • Laboratoires Pierre Fabre SA
  • Les Laboratoires Servier
  • Lupin Ltd
  • Merck & Co., Inc.
  • Mitsubishi Tanabe Pharma Corporation
  • Novartis AG
  • Pfizer Inc.
  • PT Kalbe Farma Tbk
  • Recordati S.p.A.
  • Sanofi SA
  • Shanghai Pharmaceutical Co Ltd
  • Sun Pharmaceutical Industries Inc
  • Takeda Pharmaceutical Company Limited
  • Yangtze River Pharmaceutical Group
Note: Product cover images may vary from those shown
Adroll
adroll